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Keratinocytes undergoing terminal differentiation are
characterized by well-de®ned changes in protein
expression, which contribute towards the transfor-
mation of cytoarchitecture and epithelial morphol-
ogy. Characteristic patterns of desmosomal cadherins
are tightly regulated and distinct isoforms are
expressed during development and differentiation of
epithelial tissues. Desmocollin-1 is strictly con®ned
to suprabasal layers of epidermis, but it is absent in
mitotically active, basal keratinocytes. This raises the
question of whether basal desmocollin-1 could alter
desmosomal functions and compromise keratinocyte
proliferation, strati®cation, or early differentiation in
skin. In this study, we misexpressed human desmo-
collin-1 in mouse epidermis, under control of the
keratin-14 promoter. Transgenic animals were
generated, which showed a speci®c expression of
transgenic human desmocollin-1 in epidermal basal
cells. High level transgenic expression, which was
equal to or greater than endogenous protein levels,
was observed in mice with multiple copy integration
of the transgene. A punctate distribution of desmo-
collin-1 was demonstrated at the cell membrane by
indirect immuno¯uorescence. Transgenic human
desmocollin-1 colocalized with endogenous desmo-
somal marker proteins, indicating ef®cient incor-
poration into desmosomes. Transgenic mice did not
display any obvious abnormalities, either in the his-
tology of skin and hair follicles, or in the ultra-
structure of desmosomes. These observations suggest
that desmocollin-1 can function as a desmosomal
cadherin both in basal and suprabasal cells. We pro-
pose that the differentiation-speci®c desmocollin
isoforms desmocollin-1 and desmocollin-3 are func-
tionally equivalent in basal epidermal cells and sug-
gest that their changing expression patterns are
markers, but not regulators, of the initial steps in
keratinocyte differentiation. Key words: cadherins/cell
adhesion/desmosomes/keratinocytes. J Invest Dermatol
116:144±149, 2001
D
esmosomes play an important role in cell adhesion
and maintenance of tissue structure in the epidermis.
Previous studies have identi®ed two structurally
related but distinct families of desmosomal cadher-
ins, named desmocollins (Dsc) and desmogleins,
which both comprise three different isoforms (for review see
Garrod et al, 1999). The genes of both families are closely linked
and organized as a single cluster that is localized on chromosome 18
in both mouse and human. Due to alternative splicing, all three Dsc
are expressed as two variants. Only the longer a-form binds
plakoglobin, whereas the function of the shorter b-form is not yet
understood.
In epidermal tissue different isoforms of desmosomal cadherins
are expressed during development and in adult differentiating skin.
These complex expression patterns have been well described in
several studies (Arnemann et al, 1993; Legan et al, 1994; King et al,
1995; 1997; Nuber et al, 1995; 1996; Yue et al, 1995; SchaÈfer et al,
1996). The biologic signi®cance of the different isoforms and
whether they have divergent properties or functions in desmosomal
adhesion is not known.
Dsc1 and Dsc3 are speci®cally expressed in strati®ed epithelia,
and expression of Dsc1 is further restricted to the epidermis,
tongue, and lymph node (King et al, 1996; Nuber et al, 1996). Dsc1
expression is most prominent in the higher, terminally differentiat-
ing cell layers (Legan et al, 1994). In contrast, high levels of Dsc3
are detectable in the basal and lower spinous layers. Although Dsc1
and Dsc3 can occur within the same desmosome, their overall
distribution is reciprocally graded throughout the thickened
epidermis of the bovine nose (North et al, 1996). It was speculated
that desmosomes, which incorporate variant isoforms, are distin-
guished by differential adhesiveness, and de®ne a gradient that may
be involved in keratinocyte positioning during differentiation or
development (North et al, 1996; Garrod et al, 1999). This may
further suggest a possible regulatory role for Dsc in tissue
morphogenesis or cell migration (Garrod et al, 1996; King et al,
1996). The importance of classical cadherins in this respect is well
established (Takeichi, 1991). Putative functions of their desmoso-
mal counterparts as regulators in morphogenesis or differentiation
have not yet been evaluated, however.
The expression pattern of Dsc1 is particularly interesting, as it is
exclusively expressed in suprabasal cells but not in the basal layer of
dividing keratinocytes (Legan et al, 1994; Nuber et al, 1996). Dsc1
expression was also demonstrated to correlate with the onset of
keratinization (King et al, 1996), suggesting further that this isoform
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is associated with keratinocytes that are committed towards
terminal differentiation.
This raises the question of whether Dsc1 expression in basal cells
could alter desmosomal functions, such as their interactions with
the intermediate ®lament network, and whether basal Dsc1 is
compatible with keratinocyte proliferation or migration of
stratifying cells into the spinous layer. This question also has wider
implications. Desmosomal cell adhesion has been suggested as a
potential inhibitor of tumor cell invasion (Tselepis et al, 1998),
implying that desmosomal cadherins could constitute potential
candidates for gene therapeutic intervention in skin-related cancers.
Dsc1 could prove particularly useful in this regard, as it is strongly
expressed in differentiated keratinocytes and is thought to increase
desmosomal adhesion during differentiation. In addition, Dsc1 was
shown to inhibit invasive behavior in L929 cells (Tselepis et al,
1998). In this study we have investigated the consequences of
human Dsc1 expression in basal keratinocytes in vivo, using a novel
transgenic mouse model. This approach has allowed a functional
evaluation of Dsc1 expression in basal keratinocytes and an
investigation of the possible consequences for epidermal keratino-
cyte differentiation and skin morphogenesis.
MATERIALS AND METHODS
Preparation of the keratin-14 (K14) expression cassette
construct The K14 expression cassette, pG3ZK14, was kindly
provided by Elaine Fuchs (Wang et al, 1997). The single EcoRI site at
the 5¢ side of the promoter (Fig 1A) was used to introduce additional XhoI
and BglII sites, to allow the recovery of the K14-DSC1a fragment for
pronuclear injection. A full-length human Dsc1a cDNA was obtained by
linking the 3¢ sequences of clone K1 to K55/24, using an internal ApaI site
(King et al, 1993). This fragment was subcloned into the BamH1 site of
pG3ZK14, using the BamH1 site of pBluescript SK and an internal site
within the 3¢-untranslated sequence of the gene. A fragment containing the
K14 promoter, b-globin intron, full-length human Dsc1 cDNA, and the
polyadenylation site of the K14 gene was recovered by digestion with XhoI
and HindIII (Fig 1A). This fragment was further puri®ed, using the
GENECLEAN II kit (Anachem) and Spin-X centrifuge tube ®lters
(Costar). The DNA was dissolved in injection buffer [5 mM Tris pH 7.4;
0.15 mM ethylenediamine tetraacetic acid (EDTA)] and the ®nal
concentration was adjusted to 5 ng per ml.
Pronuclear injection and screening of transgenic mouse Isolation
of fertilized mouse eggs and pronuclear injection of DNA fragments was
carried out as described previously (Hogan et al, 1994), using (CBA/Ca 3
C57BL/10)F1 mice. M2 and M16 media for embryo culture were obtained
from Sigma. Embryos were reimplanted into pseudopregnant recipients,
either after microinjection or at the two cell stage, as described previously
(Hogan et al, 1994).
Genomic DNA was isolated from tails, digested in 100 mM Tris pH 8.0,
5 mM EDTA, 200 mM NaCl, 0.2% sodium dodecyl sulfate (SDS), 100 mg
per ml proteinase K at 55°C overnight, puri®ed by phenol/chloroform
extraction and dissolved in water. Samples of genomic mouse DNAs were
analyzed for transgene integration by polymerase chain reaction (PCR),
using a primer that binds within the b-globin intron (5¢-ACCATG-
TTCATGCCTTCTTC-3¢) and a Dsc1-speci®c primer (5¢-GTGTAA-
TTCTGTGCAGCA-3¢). In addition, DNA slot blot hybridization analysis
was carried out, using a labeled fragment (XbaI/HindIII) containing the 3¢-
untranslated region of Dsc1 and the K14 polyadenylation site as probe.
Blots were analyzed by autoradiography and signals were quanti®ed by
densitometry, using a Melico Photolog Transmission densitometer.
Monoclonal antibodies and rabbit antisera Transgenic Dsc1 was
detected with the human speci®c monoclonal antibody DSC1-U100
(Progen) and with monoclonal antibody A4 (King et al, 1996), which also
detects endogenous rodent Dsc1. These antibodies were localized with
¯uorescein isothiocyanate (FITC) conjugated rabbit antimouse IgG
(Dako). Polyclonal antiserum (antiPG7) against the N-terminus of
plakoglobin (residues 5±304) was kindly provided by Tony Magee. The
polyclonal antiserum against desmoplakin has been published before
(Arnemann et al, 1993). The FITC conjugated donkey antimouse IgG
and Texas red conjugated donkey antirabbit IgG used in double staining
experiments were obtained from Jackson Immunoresearch Laboratories.
Western blot analysis Mouse skin was heated for 1 min at 65°C in
phosphate-buffered saline (PBS). The epidermis was separated from
the dermis using a fresh razorblade and lyzed in 60 mM Tris pH 6.8,
5% b-mercaptoethanol, 1% SDS, 10% glycerol. Western blot
analysis was carried out as described before (King et al, 1995), using
8% polyacrylamide gels.
Indirect immuno¯uorescence and confocal microscopy Cryostat
sections embedded in OCT embedding medium were prepared from
frozen tissue (5±8 mm), using a cryotome 620 (Shandon). Sections were
blocked in 1% bovine serum albumin/PBS. Incubation with primary
Figure 1. Generation and screening of transgenic mice. (A) Map of
the K14-Dsc1a expression cassette. (B) Slot blot analyses. 5 mg tail DNAs
were blotted onto nitrocellulose and probed with a labeled HindIII/XbaI
fragment that contains the 3¢-noncoding region of human Dsc1 and the
polyadenylation site of the K14 cassette. The identi®cation numbers of
transgene-carrying mice are indicated. The tail DNA sample used as
positive control + was isolated from a founder mouse that died in infancy.
The negative control sample ± was derived from a normal (CBA/Ca 3
C57BL/10)F1 mouse. Figures in brackets indicate estimated transgene copy
number. A parallel blot was probed with a genomic fragment containing
intron 3 of the mouse Dsc1 gene to con®rm equal loading of sample DNA
(data not shown). (C) Detection of transgenic Dsc1a expression by Western
blotting. Western blot analysis of tail epidermis samples from a transgenic
mouse (+) and noncarrier litter mate (±). Blots probed with A4 (lanes 1 and
2) show detection of Dsc1 (a and b forms) in transgenic and nontransgenic
animals. Blots probed with the human Dsc1-speci®c monoclonal antibody
show human Dsc1a in transgenic (lane 3) but not in nontransgenic (lane 4)
mice. Reactivity with a high molecular weight band (indicated as *) and
with cytokeratins (CK) was found in transgenic and nontransgenic animals
and was due to nonspeci®c binding of the secondary antibody, as these
bands were also detected in a control blot (lanes 5 and 6), where only
horseradish peroxidase conjugated rabbit antimouse serum was used.
Positions of the 69 and 112 kDa molecular weight markers are indicated in
the right panel.
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antibodies was carried out for 1 h. All monoclonal antibodies were directly
applied as hybridoma supernatants; the rabbit polyclonal antisera were
diluted 1:200. Secondary rabbit antimouse conjugates were diluted 1:50
and were applied for a further 45 min. Secondary donkey antibodies were
diluted 1:20 and applied for 1 h. Sections were washed in PBS/0.1%
Nonidet P-40 and mounted with Citi¯uor (Agar Scienti®c). Fluorescent
specimens were analyzed using an Olympus microscope with CCD camera,
which was operated by Delta Vision computer software (Applied
Precision). Alternatively, double-stained specimens were examined using
a Leica DM RXE confocal microscope.
Yeast two-hybrid screening Cytoplasmic tails of human Dsc1b and
Dsc1a were ampli®ed from pG3ZK14-Dsc1a using an oligonucleotide
corresponding to amino acids 591±597 (5¢-GCCGAATTCCCAGAA-
GACATAGCCGAGC-3¢) and an antisense oligonucleotide in the 3¢-
untranslated region (5¢-GCCGGATCCGCAGATGCTGCTAACAT-
TCTGC-3¢). The ampli®ed fragment was digested with EcoR1/BamH
and cloned in frame to the Gal4 DNA binding domain in plasmid pGBD
(James et al, 1996), thus creating pAS-Dsc1a. Full-length human
plakoglobin was cloned into pACTII (Clontech); the resulting plasmid
was named pACT-PG. Yeast strain CG1945 was transformed with
combinations of pGBD and pGAD constructs and colonies were assayed
for their ability to grow on 3-aminotriazole (Sigma) and for b-galactosidase
activity, as described in Durfee et al (1993). The Dsc1a cytoplasmic tail was
also used as bait to screen an HaCaT cDNA library (Clontech). cDNA
inserts of positive clones were ampli®ed by PCR, sequenced using the
BigDye Seq sequencing kit (Perkin Elmer), and identi®ed by sequence
homology using the Basic logical alignment search tool (BLAST, Altschul
et al, 1990).
RESULTS
High level expression of transgenic human Dsc1a in basal
epidermal keratinocytes The human Dsc1a gene was
subcloned into an expression cassette that is regulated by the K14
promoter (Fig 1A), thus facilitating its speci®c expression in basal
epidermal cells. Pronuclear injections were carried out and eight
founder mice, which harboured copies of the integrated transgene,
were identi®ed by PCR and subsequently by slot blot DNA
hybridization (Fig 1B). A further transgenic animal (indicated as +
in Fig 1B) died postnatally at day 13. The copy numbers of
integrated transgene were determined from the signal intensities
and are indicated in brackets in Fig 1(B). Heterozygous and
homozygous mice were bred from the founder with the highest
copy number of integrated transgene (Fig 1B, mouse 6), and from
two founder mice of intermediate copy number (mice 27 and 28).
The expression of transgenic Dsc1a was analyzed by
immuno¯uorescence staining of frozen tail sections. The human-
speci®c monoclonal antibody DSC1-U100 was used, as this
allowed the transgenic human and endogenous mouse Dsc1
proteins to be distinguished. Transgenic Dsc1a was detected in
the heterozygous progeny of founder mice 6, 27, and 28 (Fig 2A,
B), which carried the transgene, but not in wild-type littermates
(Fig 2D).
The expression of transgenic Dsc1a was patchy in the epidermis
of animals derived from founders 27 and 28, and expression was
absent in up to a third of basal cells (Fig 2B). In contrast,
heterozygous carriers that were bred from the high copy founder
(Fig 1B, mouse 6) showed strong and speci®c staining for human
Dsc1a in 80%±100% of basal keratinocytes (Fig 2A). These mice
were used in subsequent analysis of the effects of Dsc1 misexpres-
sion in basal epidermal cells. Transgenic Dsc1a expression was
restricted to basal keratinocytes, hair follicle (outer root sheath), and
sebaceous gland (Fig 2A, C), with very little transgenic Dsc1a
detectable in suprabasal cells.
To estimate the relative expression levels of transgenic Dsc1a,
compared with the endogenous protein, tail sections of transgenic
and wild-type animals were analyzed using the monoclonal
antibody A4 (Fig 3). This antibody is speci®c for Dsc1, but
recognizes both the human and murine protein. No Dsc1 was
detected in basal keratinocytes in nontransgenic animals, using A4
or DSC1-U100. This observation con®rms that endogenous Dsc1
is excluded from the basal layer in mouse skin. In contrast,
transgenic animals showed strong staining for transgenic human
Dsc1 in the basal layer, using both antibodies (Fig 3A, B). The
expression of transgenic Dsc1a was comparable to endogenous
suprabasal levels of mouse Dsc1, as indicated by a similar staining
intensity, using the cross-reactive antibody A4 (compare Fig 3B
with 3D). We conclude that the graded distribution of Dsc1 that
was previously speculated to control keratinocyte positioning or to
regulate epidermal differentiation (North et al, 1996) had been
eliminated in these mice.
Expression of the transgenic Dsc1a protein was further analyzed
by Western blotting, using the human-speci®c antibody DSC1-
U100 as well as the cross-reactive monoclonal antibody A4. A
single band, corresponding in size to mouse Dsc1a, was speci®cally
detected by DSC1-U100 in transgenic mice. This result suggests
that only full-length human Dsc1a is expressed within the basal
layer (Fig 1C).
Co-localization of transgenic human Dsc1 with desmo-
plakin and plakoglobin To analyze whether transgenic Dsc1a
was incorporated into desmosomes, its cellular localization was
studied by confocal microscopy of cryostat sections that had been
costained with the human Dsc1-speci®c monoclonal DSC1-U100
and with DP121, a polyclonal antiserum against desmoplakin
(Fig 4). Examination at lower magni®cation again showed that the
transgenic human Dsc1 was restricted to basal keratinocytes and
that it had a generally similar distribution to endogenous
desmoplakin (Fig 4A). Again, no transgenic Dsc1 was found
within suprabasal layers. The staining was predominantly punctate,
which would be consistent with incorporation of exogenous Dsc1
into the desmosomes of basal cells. Analysis at higher magni®cation,
however, showed that the Dsc1 and desmoplakin staining were not
completely identical and did not overlap entirely (Fig 4B). This
partial overlap may re¯ect the very different location of the two
Figure 2. Transgenic Dsc1 is detectable in basal epidermal cells,
hair follicle, and sebaceous gland. Tissues from the heterozygous
transgenic progeny of founder mouse 6 (A and C) and 28 (B), and a
nontransgenic control mouse (D), were analyzed by immuno¯uorescence
staining, using the monoclonal human Dsc1-speci®c antibody DSC1-
U100. Sections of tail (A, B, and D) and back skin (C) are shown. The
positions of epidermis (E) and dermis (D) are indicated. Small arrowheads
indicate positively stained outer root sheath in A (ORS) and sebaceous
glands in C. Large arrowheads indicate the position of the basement
membrane in B and D. Scale bar: 50 mm.
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proteins within the structure of the desmosome and also the high
resolution of confocal microscopy. This interpretation is supported
by the observation of comparable, partially overlapping patterns for
endogenous Dsc3 and desmoplakin (Fig 4C). The distribution of
transgenic Dsc1a and endogenous plakoglobin was also analyzed in
transgenic mice (Fig 4D), using DSC1-U100 and the rabbit
polyclonal antiserum antiPG7. Dsc1 and plakoglobin were again
detected in partially overlapping, punctate patterns at the surface of
basal keratinocytes similar to the colocalization found for Dsc1 and
desmoplakin. These data are consistent with the incorporation of
transgenic Dsc1a into desmosomes in basal epidermal keratinocytes.
Histologic and electron microscopic analysis of transgenic
and wild-type mice All the transgenic animals examined
appeared to be normal. No gross pathologic or morphologic
abnormalities were observed either in founder mice or in
heterozygous or homozygous transgenic progeny. This
observation suggests that expression of Dsc1a within the basal
layer is compatible with normal strati®cation, development of
epidermis, and differentiation. Homozygous transgenic animals,
aged 17 and 34 d, were analyzed for possible histologic and
morphologic alterations. Sections of tail, back skin, footpad, and
tongue were examined by conventional hematoxylin and eosin
staining and compared with tissues from nontransgenic littermates.
No obvious abnormalities were found in any of these tissues (data
not shown), suggesting that expression of Dsc1a in basal cells does
not interfere with epidermal development or differentiation in
adult skin or tongue. Although transgenic Dsc1a was strongly
expressed in the outer root sheath, there was no evidence for
morphologic changes or abnormalities in either hair follicle or hair.
Ultrastructural analysis of tail, back skin, tongue, and footpad
from transgenic mice and noncarrier littermates was carried out by
conventional electron microscopy. The ultrastructure of desmo-
somes appeared to be normal in tissues from 17-d-old and 34-d-old
Figure 3. High level expression of basal Dsc1 in transgenic mice
with high copy transgene integration. Cryostat tail sections of a
heterozygous transgenic carrier mouse (A and B) and a nontransgenic
littermate (C and D) were analyzed by immuno¯uorescence staining, using
the human Dsc1 speci®c antibody DSC1-U100 (A and C) or the mouse
and human reactive Dsc1 antibody A4 (B and D). The orientation of
dermis (D) and epidermis (E) is indicated and the position of the basement
membrane is marked with arrowheads. Scale bar: 10 mm.
Figure 4. Transgenic Dsc1a colocalizes with
desmoplakin and plakoglobin in basal epider-
mal keratinocytes. Cryostat tail sections were
costained for transgenic Dsc1 (A1, B1, and D1,
green staining), endogenous desmoplakin (A2 and
B2, red staining), or plakoglobin (D2, red stain-
ing), as indicated in the images. Overlay stainings
are shown in A3, B3, C, and D3. Samples were
examined using a Leica DM RXE confocal mi-
croscope. Co-localization of transgenic Dsc1 with
desmosomal marker proteins is indicated with ar-
rowheads. Comparable staining patterns were ob-
served for endogenous Dsc3 and desmoplakin, as
shown in panel C. Basal (B) and spinous (S) cells
are indicated in A-C. Panel D shows the apical
and lateral surfaces of a basal cell and the overlay
(D3) shows partially colocalized punctate staining
for transgenic Dsc1a and endogenous plakoglobin.
Scale bars: 1 mm.
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transgenic mice and no signi®cant variations were found in
desmosome numbers (data not shown). Further, no alterations
were apparent in the density and distribution of cytokeratin
®laments or in their associations with desmosomes. Although
transgenic Dsc1a was strongly detectable by immuno¯uorescence
staining, attempts to localize the protein by immunogold labeling
were unsuccessful as the epitopes recognized by DSC1-U100 and
A4 did not survive ®xation. These analyses suggest that transgenic
animals do not display abnormalities in morphology, histology, or
ultrastructure that could be attributed to overexpression of Dsc1a in
basal epidermal keratinocytes.
Cytoplasmic interactions of Dsc1 Misexpression of transgenic
Dsc1a suggested that this isoform was able to function as a
desmosomal cadherin in basal as well as suprabasal epidermal cells.
In strati®ed epithelia, however, individual Dsc could still play
distinct roles in ®ne-tuning desmosome functions or in the
recruitment of speci®c plaque proteins. To address the possible
functional diversity of Dsc isoforms, their cytoplasmic domains
were analyzed for differential interactions with cellular proteins.
We have previously studied putative associations of Dsc3 and Dsc2
with cellular proteins in cultured human foreskin keratinocytes
using immune-precipitation analysis (data not shown). In these
experiments, associations of both Dsc2 and Dsc3 with plakoglobin
were demonstrated. As Dsc1 is not expressed in cultured
keratinocytes, the question of differential cytoplasmic associations
of this isoform was analyzed using the yeast two-hybrid system.
The interaction of the cytoplasmic domain of Dsc1a with
plakoglobin was directly demonstrated by assaying yeast that
harboured both the Dsc1a-Gal4 bait and pACT-PG for
activation of b-galactosidase expression and for their ability to
grow on 3-aminotriazole (Table I). We were unable to examine
cytoplasmic interactions of the Dsc3a tail, because the Gal4-
binding-domain-Dsc3a fusion protein induced high background
expression of both His3 and b-galactosidase. Interactions of the
Dsc1a tail were further studied by yeast two-hybrid screening of an
HaCaT cDNA library. Sixty to seventy percent of the positive
colonies contained full-length plakoglobin, fused in frame to the
Gal4 activator domain, con®rming that the primary cytoplasmic
interaction of Dsc1a was with plakoglobin. No other multiple hits
were identi®ed from the remaining colonies. This experiment
suggested that Dsc1 interacts primarily with plakoglobin and is
equivalent in this respect to the other Dsc isoforms.
DISCUSSION
In this study, the functional signi®cance of differentiation-speci®c
isoforms of Dsc was addressed, using an in vivo transgenic mouse
model. Mice that showed strong expression of transgenic Dsc1a in
their basal epidermal keratinocytes were generated and analyzed for
possible alterations in desmosomal ultrastructure and epidermal
tissue abnormalities. No obvious anomalies were found, however,
suggesting that basal expression of Dsc1 is compatible with normal
epidermal differentiation and development.
These observations were somewhat surprising in view of
previous transgenic misexpression experiments, which demon-
strated the functional diversity of differentiation-speci®c cytoker-
atins in the epidermis. Misexpression of K16 in basal epidermal cells
caused a dramatic phenotype that involved hyperproliferation of
basal keratinocytes and hyperkeratotic skin (Paladini and
Coulombe, 1998). Furthermore, K18, a cytokeratin of simple
epithelia, did not rescue the mutant phenotype when it was
expressed in the basal layer of K14 knockout mice (Hutton et al,
1998). In contrast, we conclude here that the exclusion of Dsc1
from basal keratinocytes has little signi®cance for desmosome
function or for speci®c desmosomal interactions with the basal K5±
K14 cytokeratin network.
Transgenic Dsc1a was detected as punctate staining that partially
colocalized with desmoplakin and plakoglobin. This observation
indicated that some of the exogenous basal Dsc1a was associated
with desmosomal marker proteins and thus appeared to be
incorporated into desmosomes. The cytoplasmic interactions of
Dsc1 were further addressed using the yeast two-hybrid system, as
immune-precipitation of Dsc1 was not feasible from cultured
keratinocytes. These experiments suggested that Dsc1 interacted
predominantly with plakoglobin. We speculate that all Dsc are
equivalent in this respect and suggest further that Dsc1 functions
normally as a desmosomal cadherin when it is misexpressed in basal
epidermal keratinocytes. The signi®cance of the different Dsc
isoforms is not known. We have demonstrated here that Dsc1 is
apparently not involved in the regulation of strati®cation or early
events of epidermal differentiation. It remains unclear, however,
whether its upregulation in the suprabasal layers of normal
epidermis re¯ects functional differences. In particular, we cannot
exclude the possibility that suprabasal Dsc1 engages in interactions
that, though not relevant in basal keratinocytes, may still be
important for tissue integrity or desmosomal adhesion in the
spinous or granular layer.
Associations between Dsc1a and plakophilin-1 have been
previously demonstrated by in vitro overlay assays (Smith and
Fuchs, 1998). Consistent with these observations, we found weak
associations between Dsc1a and plakophilin-1, using the yeast two-
hybrid system (Molly Strom, unpublished observations).
Plakophilins are nuclear proteins that are recruited to the
desmosomal plaque in some tissues. Interestingly, like Dsc1,
plakophilin-1 expression is restricted to strati®ed epithelia and its
desmosomal expression is most prominent in the suprabasal layers
(Heid et al, 1994; Mertens et al, 1996; Schmidt et al, 1997).
Furthermore, novel plaque proteins have been recently identi®ed
that are expressed both in tissue- and differentiation-dependent
manners (Ruhrberg et al, 1996; 1997). It remains to be clari®ed
whether diverse desmosomal cadherins differentially associate with
cytoplasmic or plaque proteins and whether this leads to
modi®cations of desmosomal adhesion in suprabasal cells.
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